0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Travel Sickness Drugs Market Research Report 2024
Published Date: January 2024
|
Report Code: QYRE-Auto-21S526
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Travel Sickness Drugs Market Insights and Forecast to 2028
BUY CHAPTERS

Global Travel Sickness Drugs Market Research Report 2024

Code: QYRE-Auto-21S526
Report
January 2024
Pages:78
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Travel Sickness Drugs Market Size

The global Travel Sickness Drugs market was valued at US$ 394 million in 2023 and is anticipated to reach US$ 482 million by 2030, witnessing a CAGR of 2.9% during the forecast period 2024-2030.

Travel Sickness Drugs Market

Travel Sickness Drugs Market

Travel Sickness is a common problem in people traveling by car, train, airplanes, and especially boats. Motion sickness is a condition experienced by patient caused due to difference between the visually perceived motion and vestibular system’s senses of movement. Motion sickness is characterized by a set of symptoms such as nausea, fatigue, and dizziness.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Travel Sickness Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Travel Sickness Drugs.

Report Scope

The Travel Sickness Drugs market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Travel Sickness Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Travel Sickness Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Travel Sickness Drugs Market Report

Report Metric Details
Report Name Travel Sickness Drugs Market
Accounted market size in 2023 US$ 394 million
Forecasted market size in 2030 US$ 482 million
CAGR 2.9%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Anticholinergic
  • Antihistamines
  • Others
Segment by Application
  • Adults
  • Children
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company GlaxoSmithKline, Prestige Brands, WellSpring Pharmaceutical Corporation, Baxter International, Viatris, Sandoz, Pfizer, Myungmoon Pharm, Caleb Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Travel Sickness Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Travel Sickness Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Travel Sickness Drugs Market growing?

Ans: The Travel Sickness Drugs Market witnessing a CAGR of 2.9% during the forecast period 2024-2030.

What is the Travel Sickness Drugs Market size in 2030?

Ans: The Travel Sickness Drugs Market size in 2030 will be US$ 482 million.

Who are the main players in the Travel Sickness Drugs Market report?

Ans: The main players in the Travel Sickness Drugs Market are GlaxoSmithKline, Prestige Brands, WellSpring Pharmaceutical Corporation, Baxter International, Viatris, Sandoz, Pfizer, Myungmoon Pharm, Caleb Pharmaceuticals

What are the Application segmentation covered in the Travel Sickness Drugs Market report?

Ans: The Applications covered in the Travel Sickness Drugs Market report are Adults, Children

What are the Type segmentation covered in the Travel Sickness Drugs Market report?

Ans: The Types covered in the Travel Sickness Drugs Market report are Anticholinergic, Antihistamines, Others

1 Travel Sickness Drugs Market Overview
1.1 Product Overview and Scope of Travel Sickness Drugs
1.2 Travel Sickness Drugs Segment by Type
1.2.1 Global Travel Sickness Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Anticholinergic
1.2.3 Antihistamines
1.2.4 Others
1.3 Travel Sickness Drugs Segment by Application
1.3.1 Global Travel Sickness Drugs Market Value by Application: (2024-2030)
1.3.2 Adults
1.3.3 Children
1.4 Global Travel Sickness Drugs Market Size Estimates and Forecasts
1.4.1 Global Travel Sickness Drugs Revenue 2019-2030
1.4.2 Global Travel Sickness Drugs Sales 2019-2030
1.4.3 Global Travel Sickness Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Travel Sickness Drugs Market Competition by Manufacturers
2.1 Global Travel Sickness Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Travel Sickness Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Travel Sickness Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Travel Sickness Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Travel Sickness Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Travel Sickness Drugs, Product Type & Application
2.7 Travel Sickness Drugs Market Competitive Situation and Trends
2.7.1 Travel Sickness Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Travel Sickness Drugs Players Market Share by Revenue
2.7.3 Global Travel Sickness Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Travel Sickness Drugs Retrospective Market Scenario by Region
3.1 Global Travel Sickness Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Travel Sickness Drugs Global Travel Sickness Drugs Sales by Region: 2019-2030
3.2.1 Global Travel Sickness Drugs Sales by Region: 2019-2024
3.2.2 Global Travel Sickness Drugs Sales by Region: 2025-2030
3.3 Global Travel Sickness Drugs Global Travel Sickness Drugs Revenue by Region: 2019-2030
3.3.1 Global Travel Sickness Drugs Revenue by Region: 2019-2024
3.3.2 Global Travel Sickness Drugs Revenue by Region: 2025-2030
3.4 North America Travel Sickness Drugs Market Facts & Figures by Country
3.4.1 North America Travel Sickness Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Travel Sickness Drugs Sales by Country (2019-2030)
3.4.3 North America Travel Sickness Drugs Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Travel Sickness Drugs Market Facts & Figures by Country
3.5.1 Europe Travel Sickness Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Travel Sickness Drugs Sales by Country (2019-2030)
3.5.3 Europe Travel Sickness Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Travel Sickness Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Travel Sickness Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Travel Sickness Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Travel Sickness Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Travel Sickness Drugs Market Facts & Figures by Country
3.7.1 Latin America Travel Sickness Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Travel Sickness Drugs Sales by Country (2019-2030)
3.7.3 Latin America Travel Sickness Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Travel Sickness Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Travel Sickness Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Travel Sickness Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Travel Sickness Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Travel Sickness Drugs Sales by Type (2019-2030)
4.1.1 Global Travel Sickness Drugs Sales by Type (2019-2024)
4.1.2 Global Travel Sickness Drugs Sales by Type (2025-2030)
4.1.3 Global Travel Sickness Drugs Sales Market Share by Type (2019-2030)
4.2 Global Travel Sickness Drugs Revenue by Type (2019-2030)
4.2.1 Global Travel Sickness Drugs Revenue by Type (2019-2024)
4.2.2 Global Travel Sickness Drugs Revenue by Type (2025-2030)
4.2.3 Global Travel Sickness Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Travel Sickness Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Travel Sickness Drugs Sales by Application (2019-2030)
5.1.1 Global Travel Sickness Drugs Sales by Application (2019-2024)
5.1.2 Global Travel Sickness Drugs Sales by Application (2025-2030)
5.1.3 Global Travel Sickness Drugs Sales Market Share by Application (2019-2030)
5.2 Global Travel Sickness Drugs Revenue by Application (2019-2030)
5.2.1 Global Travel Sickness Drugs Revenue by Application (2019-2024)
5.2.2 Global Travel Sickness Drugs Revenue by Application (2025-2030)
5.2.3 Global Travel Sickness Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Travel Sickness Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GlaxoSmithKline
6.1.1 GlaxoSmithKline Corporation Information
6.1.2 GlaxoSmithKline Description and Business Overview
6.1.3 GlaxoSmithKline Travel Sickness Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GlaxoSmithKline Travel Sickness Drugs Product Portfolio
6.1.5 GlaxoSmithKline Recent Developments/Updates
6.2 Prestige Brands
6.2.1 Prestige Brands Corporation Information
6.2.2 Prestige Brands Description and Business Overview
6.2.3 Prestige Brands Travel Sickness Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Prestige Brands Travel Sickness Drugs Product Portfolio
6.2.5 Prestige Brands Recent Developments/Updates
6.3 WellSpring Pharmaceutical Corporation
6.3.1 WellSpring Pharmaceutical Corporation Corporation Information
6.3.2 WellSpring Pharmaceutical Corporation Description and Business Overview
6.3.3 WellSpring Pharmaceutical Corporation Travel Sickness Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 WellSpring Pharmaceutical Corporation Travel Sickness Drugs Product Portfolio
6.3.5 WellSpring Pharmaceutical Corporation Recent Developments/Updates
6.4 Baxter International
6.4.1 Baxter International Corporation Information
6.4.2 Baxter International Description and Business Overview
6.4.3 Baxter International Travel Sickness Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Baxter International Travel Sickness Drugs Product Portfolio
6.4.5 Baxter International Recent Developments/Updates
6.5 Viatris
6.5.1 Viatris Corporation Information
6.5.2 Viatris Description and Business Overview
6.5.3 Viatris Travel Sickness Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Viatris Travel Sickness Drugs Product Portfolio
6.5.5 Viatris Recent Developments/Updates
6.6 Sandoz
6.6.1 Sandoz Corporation Information
6.6.2 Sandoz Description and Business Overview
6.6.3 Sandoz Travel Sickness Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Sandoz Travel Sickness Drugs Product Portfolio
6.6.5 Sandoz Recent Developments/Updates
6.7 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Travel Sickness Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Pfizer Travel Sickness Drugs Product Portfolio
6.7.5 Pfizer Recent Developments/Updates
6.8 Myungmoon Pharm
6.8.1 Myungmoon Pharm Corporation Information
6.8.2 Myungmoon Pharm Description and Business Overview
6.8.3 Myungmoon Pharm Travel Sickness Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Myungmoon Pharm Travel Sickness Drugs Product Portfolio
6.8.5 Myungmoon Pharm Recent Developments/Updates
6.9 Caleb Pharmaceuticals
6.9.1 Caleb Pharmaceuticals Corporation Information
6.9.2 Caleb Pharmaceuticals Description and Business Overview
6.9.3 Caleb Pharmaceuticals Travel Sickness Drugs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Caleb Pharmaceuticals Travel Sickness Drugs Product Portfolio
6.9.5 Caleb Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Travel Sickness Drugs Industry Chain Analysis
7.2 Travel Sickness Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Travel Sickness Drugs Production Mode & Process
7.4 Travel Sickness Drugs Sales and Marketing
7.4.1 Travel Sickness Drugs Sales Channels
7.4.2 Travel Sickness Drugs Distributors
7.5 Travel Sickness Drugs Customers
8 Travel Sickness Drugs Market Dynamics
8.1 Travel Sickness Drugs Industry Trends
8.2 Travel Sickness Drugs Market Drivers
8.3 Travel Sickness Drugs Market Challenges
8.4 Travel Sickness Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Travel Sickness Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Travel Sickness Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Travel Sickness Drugs Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Travel Sickness Drugs Sales (Units) of Key Manufacturers (2019-2024)
    Table 5. Global Travel Sickness Drugs Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Travel Sickness Drugs Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Travel Sickness Drugs Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Travel Sickness Drugs Average Price (USD/Unit) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Travel Sickness Drugs, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Travel Sickness Drugs, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Travel Sickness Drugs, Product Type & Application
    Table 12. Global Key Manufacturers of Travel Sickness Drugs, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Travel Sickness Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Travel Sickness Drugs as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Travel Sickness Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Travel Sickness Drugs Sales by Region (2019-2024) & (Units)
    Table 18. Global Travel Sickness Drugs Sales Market Share by Region (2019-2024)
    Table 19. Global Travel Sickness Drugs Sales by Region (2025-2030) & (Units)
    Table 20. Global Travel Sickness Drugs Sales Market Share by Region (2025-2030)
    Table 21. Global Travel Sickness Drugs Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Travel Sickness Drugs Revenue Market Share by Region (2019-2024)
    Table 23. Global Travel Sickness Drugs Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Travel Sickness Drugs Revenue Market Share by Region (2025-2030)
    Table 25. North America Travel Sickness Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Travel Sickness Drugs Sales by Country (2019-2024) & (Units)
    Table 27. North America Travel Sickness Drugs Sales by Country (2025-2030) & (Units)
    Table 28. North America Travel Sickness Drugs Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Travel Sickness Drugs Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Travel Sickness Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Travel Sickness Drugs Sales by Country (2019-2024) & (Units)
    Table 32. Europe Travel Sickness Drugs Sales by Country (2025-2030) & (Units)
    Table 33. Europe Travel Sickness Drugs Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Travel Sickness Drugs Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Travel Sickness Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Travel Sickness Drugs Sales by Region (2019-2024) & (Units)
    Table 37. Asia Pacific Travel Sickness Drugs Sales by Region (2025-2030) & (Units)
    Table 38. Asia Pacific Travel Sickness Drugs Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Travel Sickness Drugs Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Travel Sickness Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Travel Sickness Drugs Sales by Country (2019-2024) & (Units)
    Table 42. Latin America Travel Sickness Drugs Sales by Country (2025-2030) & (Units)
    Table 43. Latin America Travel Sickness Drugs Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Travel Sickness Drugs Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Travel Sickness Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Travel Sickness Drugs Sales by Country (2019-2024) & (Units)
    Table 47. Middle East & Africa Travel Sickness Drugs Sales by Country (2025-2030) & (Units)
    Table 48. Middle East & Africa Travel Sickness Drugs Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Travel Sickness Drugs Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Travel Sickness Drugs Sales (Units) by Type (2019-2024)
    Table 51. Global Travel Sickness Drugs Sales (Units) by Type (2025-2030)
    Table 52. Global Travel Sickness Drugs Sales Market Share by Type (2019-2024)
    Table 53. Global Travel Sickness Drugs Sales Market Share by Type (2025-2030)
    Table 54. Global Travel Sickness Drugs Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Travel Sickness Drugs Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Travel Sickness Drugs Revenue Market Share by Type (2019-2024)
    Table 57. Global Travel Sickness Drugs Revenue Market Share by Type (2025-2030)
    Table 58. Global Travel Sickness Drugs Price (USD/Unit) by Type (2019-2024)
    Table 59. Global Travel Sickness Drugs Price (USD/Unit) by Type (2025-2030)
    Table 60. Global Travel Sickness Drugs Sales (Units) by Application (2019-2024)
    Table 61. Global Travel Sickness Drugs Sales (Units) by Application (2025-2030)
    Table 62. Global Travel Sickness Drugs Sales Market Share by Application (2019-2024)
    Table 63. Global Travel Sickness Drugs Sales Market Share by Application (2025-2030)
    Table 64. Global Travel Sickness Drugs Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Travel Sickness Drugs Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Travel Sickness Drugs Revenue Market Share by Application (2019-2024)
    Table 67. Global Travel Sickness Drugs Revenue Market Share by Application (2025-2030)
    Table 68. Global Travel Sickness Drugs Price (USD/Unit) by Application (2019-2024)
    Table 69. Global Travel Sickness Drugs Price (USD/Unit) by Application (2025-2030)
    Table 70. GlaxoSmithKline Corporation Information
    Table 71. GlaxoSmithKline Description and Business Overview
    Table 72. GlaxoSmithKline Travel Sickness Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 73. GlaxoSmithKline Travel Sickness Drugs Product
    Table 74. GlaxoSmithKline Recent Developments/Updates
    Table 75. Prestige Brands Corporation Information
    Table 76. Prestige Brands Description and Business Overview
    Table 77. Prestige Brands Travel Sickness Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 78. Prestige Brands Travel Sickness Drugs Product
    Table 79. Prestige Brands Recent Developments/Updates
    Table 80. WellSpring Pharmaceutical Corporation Corporation Information
    Table 81. WellSpring Pharmaceutical Corporation Description and Business Overview
    Table 82. WellSpring Pharmaceutical Corporation Travel Sickness Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 83. WellSpring Pharmaceutical Corporation Travel Sickness Drugs Product
    Table 84. WellSpring Pharmaceutical Corporation Recent Developments/Updates
    Table 85. Baxter International Corporation Information
    Table 86. Baxter International Description and Business Overview
    Table 87. Baxter International Travel Sickness Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 88. Baxter International Travel Sickness Drugs Product
    Table 89. Baxter International Recent Developments/Updates
    Table 90. Viatris Corporation Information
    Table 91. Viatris Description and Business Overview
    Table 92. Viatris Travel Sickness Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 93. Viatris Travel Sickness Drugs Product
    Table 94. Viatris Recent Developments/Updates
    Table 95. Sandoz Corporation Information
    Table 96. Sandoz Description and Business Overview
    Table 97. Sandoz Travel Sickness Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 98. Sandoz Travel Sickness Drugs Product
    Table 99. Sandoz Recent Developments/Updates
    Table 100. Pfizer Corporation Information
    Table 101. Pfizer Description and Business Overview
    Table 102. Pfizer Travel Sickness Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 103. Pfizer Travel Sickness Drugs Product
    Table 104. Pfizer Recent Developments/Updates
    Table 105. Myungmoon Pharm Corporation Information
    Table 106. Myungmoon Pharm Description and Business Overview
    Table 107. Myungmoon Pharm Travel Sickness Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 108. Myungmoon Pharm Travel Sickness Drugs Product
    Table 109. Myungmoon Pharm Recent Developments/Updates
    Table 110. Caleb Pharmaceuticals Corporation Information
    Table 111. Caleb Pharmaceuticals Description and Business Overview
    Table 112. Caleb Pharmaceuticals Travel Sickness Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 113. Caleb Pharmaceuticals Travel Sickness Drugs Product
    Table 114. Caleb Pharmaceuticals Recent Developments/Updates
    Table 115. Key Raw Materials Lists
    Table 116. Raw Materials Key Suppliers Lists
    Table 117. Travel Sickness Drugs Distributors List
    Table 118. Travel Sickness Drugs Customers List
    Table 119. Travel Sickness Drugs Market Trends
    Table 120. Travel Sickness Drugs Market Drivers
    Table 121. Travel Sickness Drugs Market Challenges
    Table 122. Travel Sickness Drugs Market Restraints
    Table 123. Research Programs/Design for This Report
    Table 124. Key Data Information from Secondary Sources
    Table 125. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Travel Sickness Drugs
    Figure 2. Global Travel Sickness Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Travel Sickness Drugs Market Share by Type in 2023 & 2030
    Figure 4. Anticholinergic Product Picture
    Figure 5. Antihistamines Product Picture
    Figure 6. Others Product Picture
    Figure 7. Global Travel Sickness Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 8. Global Travel Sickness Drugs Market Share by Application in 2023 & 2030
    Figure 9. Adults
    Figure 10. Children
    Figure 11. Global Travel Sickness Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 12. Global Travel Sickness Drugs Market Size (2019-2030) & (US$ Million)
    Figure 13. Global Travel Sickness Drugs Sales (2019-2030) & (Units)
    Figure 14. Global Travel Sickness Drugs Average Price (USD/Unit) & (2019-2030)
    Figure 15. Travel Sickness Drugs Report Years Considered
    Figure 16. Travel Sickness Drugs Sales Share by Manufacturers in 2023
    Figure 17. Global Travel Sickness Drugs Revenue Share by Manufacturers in 2023
    Figure 18. The Global 5 and 10 Largest Travel Sickness Drugs Players: Market Share by Revenue in 2023
    Figure 19. Travel Sickness Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 20. Global Travel Sickness Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 21. North America Travel Sickness Drugs Sales Market Share by Country (2019-2030)
    Figure 22. North America Travel Sickness Drugs Revenue Market Share by Country (2019-2030)
    Figure 23. U.S. Travel Sickness Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 24. Canada Travel Sickness Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 25. Europe Travel Sickness Drugs Sales Market Share by Country (2019-2030)
    Figure 26. Europe Travel Sickness Drugs Revenue Market Share by Country (2019-2030)
    Figure 27. Germany Travel Sickness Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 28. France Travel Sickness Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. U.K. Travel Sickness Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. Italy Travel Sickness Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. Russia Travel Sickness Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. Asia Pacific Travel Sickness Drugs Sales Market Share by Region (2019-2030)
    Figure 33. Asia Pacific Travel Sickness Drugs Revenue Market Share by Region (2019-2030)
    Figure 34. China Travel Sickness Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 35. Japan Travel Sickness Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. South Korea Travel Sickness Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. India Travel Sickness Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. Australia Travel Sickness Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. Taiwan Travel Sickness Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Indonesia Travel Sickness Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Thailand Travel Sickness Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Malaysia Travel Sickness Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Philippines Travel Sickness Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Latin America Travel Sickness Drugs Sales Market Share by Country (2019-2030)
    Figure 45. Latin America Travel Sickness Drugs Revenue Market Share by Country (2019-2030)
    Figure 46. Mexico Travel Sickness Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 47. Brazil Travel Sickness Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Argentina Travel Sickness Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 49. Middle East & Africa Travel Sickness Drugs Sales Market Share by Country (2019-2030)
    Figure 50. Middle East & Africa Travel Sickness Drugs Revenue Market Share by Country (2019-2030)
    Figure 51. Turkey Travel Sickness Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 52. Saudi Arabia Travel Sickness Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 53. U.A.E Travel Sickness Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 54. Global Sales Market Share of Travel Sickness Drugs by Type (2019-2030)
    Figure 55. Global Revenue Market Share of Travel Sickness Drugs by Type (2019-2030)
    Figure 56. Global Travel Sickness Drugs Price (USD/Unit) by Type (2019-2030)
    Figure 57. Global Sales Market Share of Travel Sickness Drugs by Application (2019-2030)
    Figure 58. Global Revenue Market Share of Travel Sickness Drugs by Application (2019-2030)
    Figure 59. Global Travel Sickness Drugs Price (USD/Unit) by Application (2019-2030)
    Figure 60. Travel Sickness Drugs Value Chain
    Figure 61. Travel Sickness Drugs Production Process
    Figure 62. Channels of Distribution (Direct Vs Distribution)
    Figure 63. Distributors Profiles
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS